What is the recommended treatment for tinea corporis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended treatment for tinea corporis is oral itraconazole, 100 mg, given orally once a day, for 15 days, as it has shown a superior mycological cure rate of 87% compared to other treatments 1. When treating tinea corporis, it is essential to consider the causative agent, as different fungi may respond better to specific antifungal medications.

  • For cases caused by Trichophyton tonsurans, terbinafine appears to be a superior option 1.
  • In addition to oral antifungals, preventive measures such as avoiding skin-to-skin contact with people known to have lesions, not sharing towels and other fomites, and limiting exposure to swimming pools that have recently been associated with known outbreaks can help control the spread of the infection 1. Some key considerations when treating tinea corporis include:
  • The importance of completing the full treatment course, even after symptoms have resolved, to prevent recurrence.
  • Keeping the affected area clean and dry to promote healing and prevent the spread of the infection.
  • Avoiding sharing personal items and washing clothes, bedding, and towels in hot water to prevent reinfection or spreading the infection to others. It is crucial to note that the treatment of tinea corporis should be guided by the most recent and highest-quality evidence, and oral itraconazole, 100 mg, given orally once a day, for 15 days, is currently the recommended treatment based on the available evidence 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... Representative treatment periods are ... tinea corporis, 2 to 4 weeks; Adults: 0. 5 g daily (125 mg four times a day, 250 mg twice a day, or 500 mg/day). Pediatric patients (older than 2 years): A dosage of 10 mg/kg daily is usually adequate INDICATIONS AND USAGE Griseofulvin oral suspension, USP is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely: Tinea corporis

The recommended treatment for tinea corporis is griseofulvin (PO), with a treatment period of 2 to 4 weeks. The dosage for adults is 0.5 g daily, and for pediatric patients older than 2 years, it is 10 mg/kg daily 2 2.

From the Research

Treatment Options for Tinea Corporis

  • The standard treatment of tinea corporis is with topical antifungals 3
  • Systemic antifungal treatment is indicated if the lesion is multiple, extensive, deep, recurrent, chronic, or unresponsive to topical antifungal treatment, or if the patient is immunodeficient 3
  • Topical therapy is generally successful unless the infection covers an extensive area or is resistant to initial therapy, in which case systemic therapy may be required 4

Topical Antifungal Treatments

  • A wide range of topical antifungal drugs are used to treat tinea corporis, including azoles, allylamines, and benzylamines 5
  • Terbinafine and naftifine have been shown to be effective in achieving clinical and mycological cure 5
  • Clotrimazole has also been shown to be effective in achieving mycological cure 5
  • Azoles, allylamines, and benzylamines have similar cure rates, but most comparisons were evaluated in single studies 5

Duration of Treatment

  • Treatment duration varies from one week to two months, but in most studies this is two to four weeks 5
  • Tinea corporis and cruris infections are usually treated for two weeks, while tinea pedis is treated for four weeks with an azole or for one to two weeks with allylamine medication 4
  • Treatment should continue for at least one week after clinical clearing of infection 4

Adverse Effects

  • Adverse effects are minimal, mainly irritation and burning 5
  • Results are generally imprecise between active interventions and placebo, and between different classes of treatment 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tinea corporis: an updated review.

Drugs in context, 2020

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.